Navigation Links
Eczema Non-Profit Seeks To Shine New Light On Overlooked Condition
Date:7/1/2012

Indian Harbour Beach, Florida (PRWEB) July 01, 2012

ITSAN, a non-profit charity, is on a mission to combat the global health crisis that is Topical Steroid Addiction. The organization’s main effort is to reach Eczema patients with information about the correlation between Topical Steroids and worsening Eczema. Topical Steroids are the main medication used to treat Eczema.

“In 30 years of practice I have seen over 2,000 patients who initially had Eczema, either in youth, teen years or early adulthood. Each patient started off using Cortisone Creams. When the initial dose and potency no longer worked they were prescribed a higher potency with more frequent usage. In addition often pills and injections of cortisone were given,” recounts Dr. Rapaport.

“In all cases we decided to stop steroids and lo and behold, in one to three years, they were all cured. However, in each case the patient experienced a painful and debilitating withdrawal. They would swell, ooze, have difficulty functioning in school or work, scratch continually, and couldn’t sleep; we had to support them with other medication and keep them off steroids,” stated Dr. Rapaport.

Kelly Palace, president and Co-Founder of ITSAN, was diagnosed in 2009 with Steroid Induced Eczema caused by her Topical Steroid Addiction. Kelly decided to start a website to chronicle her recovery and alert people of the dangers associated with Topical Steroids. Since starting the site she has had over 100,000 web visits.

“I was critically covered in full body Eczema with no recourse. I was given Corticosteroid after Corticosteroid and told there was nothing else I could do. I was getting worse and worse until I found Dr. Rapaport’s articles; he saved my life,” said ITSAN President Kelly Palace.

Kelly discovered thousands of people like her, over the Internet, suffering the same Eczema like “incurable” symptoms. Whenever they stopped applying Topical Steroids their skin would flare, burn, and turn red. “Once we each discovered the research, which depicted these exact withdrawal symptoms, we knew our cure was in sight,” said Kelly Palace.

ITSAN’s goals include educating Eczema patients about this medical issue. Gaining more recognition amongst the broader medical community about Topical Steroid Addiction. Labeling changes to Topical Steroids to better warn patients, and patient treatment options for a monitored and less painful withdrawal process.

Kelly Palace has high hopes for those who are still suffering. “We hope that if you’re suffering that you get the help and support you need from the ITSAN resources and our global, community support groups.”

To learn more about Dr. Marvin Rapaport and his research on Topical Steroid Addiction, please visit http://itsan.org/research-and-resources.html#Dr._Marvin_Rapaport

About The International Topical Steroid Addiction Network

ITSAN was officially Co-Founded by Dermatologist Dr. Marvin Rapaport, full professor at UCLA Medical Center and the nations leading expert on the subject. Kelly Palace, Co-Founder and president, was one of the 2,000 patients that Dr. Rapaport treated and cured. An online community of over 100 patients with this condition also contributed ideas, money and inspiration to start ITSAN. For more information please visit http://itsan.org

Read the full story at http://www.prweb.com/releases/2012/7/prweb9659853.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Prenatal Exposure to Common Household Chemical Linked to Eczema
2. Prenatal exposure to common household chemical increases risk for childhood eczema, study says
3. Avid Collector Seeks Jimi Hendrix 1968 Electric Factory Philadelphia Concert Poster
4. Electronic data methods research seeks to build a learning health care system
5. Trial seeks to sniff out cancer
6. FDA Seeks to Limit Antibiotics in Animal Feed
7. Lighthouse Worldwide Solutions Now Monitors Air Quality in Hospitals and Operating Rooms
8. Bees shed light on human sweet perception and metabolic disorders
9. DRE Medical Equipment Unveils FX-300+ Surgical Headlight and Light Source
10. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
11. Could Sunlight Lower Your Odds for Pancreatic Cancer?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance ... greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to ... and deadly chromosome abnormality. , After struggling since birth with several health challenges, ...
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
Breaking Medicine Technology: